Headlines

Glyphosate bans have been enacted in several U.S. cities and foreign countries due to health concerns.

Motley Rice welcomes Joshua M. Neuman as senior counsel and Josey M. Richards and Alexandra A. Stulpin joined as associates at Three Logan Square in Philadelphia.

Sarah Wynn-Williams—Meta whistleblower and author of the recently released book “Careless People”—testified before the U.S. Senate April 9 about many of the company’s negative business practices.

Jazz Pharmaceuticals has agreed to pay $145 million to resolve antitrust litigation alleging pay-for-delay tactics with popular narcolepsy drug Xyrem®.

Our client lost their livelihood after being diagnosed with nonarteritic anterior ischemic optic neuropathy (NAION). Despite stopping Ozempic, they remain legally blind.

A tourist helicopter lost control and plunged into the Hudson River on April 10, 2025, claiming the lives of a family of five and the pilot.

A civil lawsuit has been filed in California federal court seeking to hold the Sinaloa Cartel and it's indicted drug kingpins responsible for the DEA special agent Kiki Camarena's brutal kidnap and murder in 1985.

Studies have linked talcum powder and ovarian cancer. Learn about the connection and related lawsuits here.

A federal lawsuit was filed today against Delta Air Lines, Inc., and its subsidiary Endeavor Air, following the crash landing of Delta Flight 4819 at Toronto Pearson International Airport on Feb. 17, 2025.

The Motley Rice Antitrust Practice Group continues to be recognized as one of the nation’s foremost plaintiffs’ antitrust class action practices.